• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LINC00346 通过调节乳腺癌细胞中的葡萄糖转运蛋白 1 来调节糖酵解。

LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells.

机构信息

Department of General Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, 121000, PR China.

Out-patient Department, Jinzhou Central Hospital, Jinzhou, Liaoning, 121000, PR China.

出版信息

Mol Cell Probes. 2020 Dec;54:101667. doi: 10.1016/j.mcp.2020.101667. Epub 2020 Sep 16.

DOI:10.1016/j.mcp.2020.101667
PMID:32946972
Abstract

Most cancer cells preferentially metabolize glucose by glycolysis rather than oxidative phosphorylation to proliferate efficiently. LncRNAs have been proposed as crucial regulators in pathophysiological processes including cell growth, apoptosis and glucose metabolism. However, little is known regarding the specific role of LINC00346 in regulating glucose metabolism in breast cancer. LINC00346 and miR-148a/b expression in breast cancer cells was detected by qRT-PCR. The relationships between LINC00346, glucose transporter 1 (GLUT1) and miR-148a/b in breast cancer cells were explored by luciferase reporter assay. Cell proliferation and apoptosis were evaluated by CCK-8 and flow cytometry analysis, respectively. Glycolysis was detected by measuring the glucose uptake and lactate production. Results showed that LINC00346 was over-expressed while miR-148a/b was low-expressed in breast cancer cells. miR-148a/b were direct targets of LINC00346 in breast cancer cells. LINC00346 knockdown inhibited cell proliferation and glycolysis, and induced apoptosis by upregulating miR-148a/b in breast cancer cells. Furthermore, we found that LINC00346 knockdown repressed GLUT1 expression in breast cancer cells by upregulating miR-148a/b. In conclusion, LINC00346 knockdown suppressed breast cancer cell glycolysis by upregulating miR-148a/b and repressing GLUT1 expression.

摘要

大多数癌细胞通过糖酵解优先代谢葡萄糖,而不是通过氧化磷酸化来高效增殖。lncRNAs 被认为是包括细胞生长、凋亡和葡萄糖代谢在内的病理生理过程中的关键调节因子。然而,关于 LINC00346 在调节乳腺癌中葡萄糖代谢的具体作用知之甚少。通过 qRT-PCR 检测乳腺癌细胞中 LINC00346 和 miR-148a/b 的表达。通过荧光素酶报告基因检测探讨乳腺癌细胞中 LINC00346、葡萄糖转运蛋白 1 (GLUT1) 和 miR-148a/b 之间的关系。通过 CCK-8 和流式细胞术分析分别评估细胞增殖和凋亡。通过测量葡萄糖摄取和乳酸生成来检测糖酵解。结果表明,LINC00346 在乳腺癌细胞中过表达,而 miR-148a/b 低表达。miR-148a/b 是乳腺癌细胞中 LINC00346 的直接靶标。LINC00346 敲低通过上调乳腺癌细胞中的 miR-148a/b 抑制细胞增殖和糖酵解,并诱导细胞凋亡。此外,我们发现 LINC00346 敲低通过上调 miR-148a/b 抑制乳腺癌细胞中 GLUT1 的表达。总之,LINC00346 敲低通过上调 miR-148a/b 并抑制 GLUT1 的表达抑制乳腺癌细胞的糖酵解。

相似文献

1
LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells.LINC00346 通过调节乳腺癌细胞中的葡萄糖转运蛋白 1 来调节糖酵解。
Mol Cell Probes. 2020 Dec;54:101667. doi: 10.1016/j.mcp.2020.101667. Epub 2020 Sep 16.
2
Aberrant expression of LINC00346 regulates cell migration and proliferation via competitively binding to miRNA-148a-3p/Dnmt1 in Hirschsprung's disease.LINC00346 的异常表达通过与 miRNA-148a-3p/Dnmt1 竞争结合来调节先天性巨结肠病中的细胞迁移和增殖。
Pediatr Surg Int. 2022 Sep;38(9):1273-1281. doi: 10.1007/s00383-022-05144-9. Epub 2022 Jul 14.
3
WBSCR22 Competes with Long Non-coding RNA Linc00346 for miR-509-5p Binding Site to Regulate Cancer Stem Cell Phenotypes of Colorectal Cancer.WBSCR22 通过与长链非编码 RNA Linc00346 竞争 miR-509-5p 结合位点调控结直肠癌肿瘤干细胞表型。
Biochem Genet. 2020 Jun;58(3):384-398. doi: 10.1007/s10528-020-09949-y. Epub 2020 Feb 1.
4
LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.LncRNA XIST 敲低通过 XIST/miRNA-148a-3p/ADAM17 通路在体外和体内抑制人鼻咽癌的恶性转化。
Biomed Pharmacother. 2020 Jan;121:109620. doi: 10.1016/j.biopha.2019.109620. Epub 2019 Nov 20.
5
Long non-coding RNA LINC00346 regulates proliferation and apoptosis by targeting miR-128-3p/SZRD1 axis in glioma.长链非编码 RNA LINC00346 通过靶向 miR-128-3p/SZRD1 轴调控胶质瘤细胞的增殖和凋亡。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9581-9590. doi: 10.26355/eurrev_202009_23046.
6
Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis.环状 RNA circDENND4C 通过 miR-760/GLUT1 轴促进结直肠癌细胞的增殖、迁移和糖酵解。
Eur Rev Med Pharmacol Sci. 2020 Mar;24(5):2387-2400. doi: 10.26355/eurrev_202003_20506.
7
Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.长链非编码 RNA SLC2A1-AS1 通过抑制 STAT3/FOXM1/GLUT1 通路调节肝癌的有氧糖酵解和进展。
Mol Oncol. 2020 Jun;14(6):1381-1396. doi: 10.1002/1878-0261.12666. Epub 2020 Mar 30.
8
Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.环状 RNA hsa_circRNA_100290 通过葡萄糖转运蛋白 1 (GLUT1) 和糖酵解作为 ceRNA 调控口腔鳞状细胞癌细胞生长。
J Cell Physiol. 2019 Nov;234(11):19130-19140. doi: 10.1002/jcp.28692. Epub 2019 Jun 11.
9
LncRNA HOTTIP facilitates the stemness of breast cancer via regulation of miR-148a-3p/WNT1 pathway.长链非编码 RNA HOTTIP 通过调控 miR-148a-3p/WNT1 通路促进乳腺癌的干性。
J Cell Mol Med. 2020 Jun;24(11):6242-6252. doi: 10.1111/jcmm.15261. Epub 2020 Apr 19.
10
Long non-coding RNA LINC00662 promotes proliferation and migration of breast cancer cells via regulating the miR-497-5p/EglN2 axis.长链非编码 RNA LINC00662 通过调节 miR-497-5p/EglN2 轴促进乳腺癌细胞的增殖和迁移。
Acta Biochim Pol. 2020 Jun 19;67(2):229-237. doi: 10.18388/abp.2020_5203.

引用本文的文献

1
LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.长链非编码 RNA 在肿瘤代谢重编程和肿瘤微环境重塑中的作用。
Front Immunol. 2024 Oct 30;15:1467151. doi: 10.3389/fimmu.2024.1467151. eCollection 2024.
2
Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications.乳腺癌中代谢调节性非编码 RNA:作用、机制及临床应用。
J Biomed Sci. 2024 Feb 26;31(1):25. doi: 10.1186/s12929-024-01013-w.
3
Long noncoding RNAs, glucose metabolism and cancer (Review).长链非编码RNA、葡萄糖代谢与癌症(综述)
Oncol Lett. 2023 Jun 22;26(2):340. doi: 10.3892/ol.2023.13925. eCollection 2023 Aug.
4
Non-coding RNAs in breast cancer: with a focus on glucose metabolism reprogramming.乳腺癌中的非编码RNA:聚焦于葡萄糖代谢重编程
Discov Oncol. 2023 May 19;14(1):72. doi: 10.1007/s12672-023-00687-2.
5
Glucose metabolism and lncRNAs in breast cancer: Sworn friend.乳腺癌中的葡萄糖代谢与长链非编码 RNA:铁哥们。
Cancer Med. 2023 Feb;12(4):5137-5149. doi: 10.1002/cam4.5265. Epub 2022 Nov 24.
6
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.乳腺癌重编程中的代谢途径:非编码 RNA 的新视角。
Cells. 2022 Sep 23;11(19):2973. doi: 10.3390/cells11192973.
7
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action.白藜芦醇在乳腺癌治疗中的应用:从细胞作用到作用机制。
Cell Mol Life Sci. 2022 Oct 4;79(11):539. doi: 10.1007/s00018-022-04551-4.
8
Long non-coding RNAs affecting cell metabolism in cancer.长非编码 RNA 对癌症中细胞代谢的影响。
Biol Direct. 2022 Oct 1;17(1):26. doi: 10.1186/s13062-022-00341-x.
9
New Insights into LINC00346 and its Role in Disease.LINC00346的新见解及其在疾病中的作用。
Front Cell Dev Biol. 2022 Jan 13;9:819785. doi: 10.3389/fcell.2021.819785. eCollection 2021.
10
The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism.长非编码 RNA 在癌症代谢中所涉及的新兴调控作用。
Mol Ther. 2021 Jul 7;29(7):2209-2218. doi: 10.1016/j.ymthe.2021.03.017. Epub 2021 Mar 26.